PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-100.00%
Negative net income growth while 1097.HK stands at 36.88%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-11.89%
Both reduce yoy D&A, with 1097.HK at -0.45%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-100.00%
Negative yoy deferred tax while 1097.HK stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-100.00%
Negative yoy SBC while 1097.HK is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-12.36%
Both reduce yoy usage, with 1097.HK at -81.04%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
277.45%
Some yoy increase while 1097.HK is negative at -82.39%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
20.72%
Some CFO growth while 1097.HK is negative at -20.35%. John Neff would note a short-term liquidity lead over the competitor.
-25.32%
Negative yoy CapEx while 1097.HK is 6.86%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
266.07%
Growth well above 1097.HK's 194.69%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-49.88%
We reduce yoy invests while 1097.HK stands at 5.31%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-199.71%
We cut debt repayment yoy while 1097.HK is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-98.18%
Negative yoy issuance while 1097.HK is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.